Current treatment options for postmenopausal vaginal atrophy

References

• CuadrosJLlanezaPMateuSDemografia y epidemiologia del climaterio en España En: Libro blanco de la menopausia en EspañaEMISAMadrid20001533
   Google Scholar
• Castelo-BrancoCCanceloMJCompounds for the treatment of atropic vaginitisExpert Opin Ther Pat2008181213851394
   Web of Science ®Google Scholar
• PalaciosSNappiREBruyniksNThe European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopauseClimacteric201821328629129553288
   PubMed Web of Science ®Google Scholar
• North American Menopause SocietyThe role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause SocietyMenopause2007143 Pt 135536917438512
   PubMed Web of Science ®Google Scholar
• PalaciosSAtrophy Murogenital. Managing urogenital atrophyMaturitas200963431531819493638
   PubMed Web of Science ®Google Scholar
• ApolihinaIGorbunovaEClinical and morphological aspects of vulvovaginal atrophyMedical Council20149109117
   Google Scholar
• PalaciosSCastelo-BrancoCCurrieHUpdate on management of genitourinary syndrome of menopause: A practical guideMaturitas201582330831326261035
   PubMed Web of Science ®Google Scholar
• Castelo-BrancoCCanceloMJVilleroJNohalesFJuliáMDManagement of post-menopausal vaginal atrophy and atrophic vaginitisMaturitas200552Suppl 1(1)4652
   Web of Science ®Google Scholar
• GodhaKTuckerKMBiehlCArcherDFMirkinSHuman vaginal pH and microbiota: an updateGynecol Endocrinol201834645145529271266
   PubMed Web of Science ®Google Scholar
• SturdeeDWPanayNInternational Menopause Society Writing GroupRecommendations for the management of postmenopausal vaginal atrophyClimacteric201013650952220883118
   PubMed Web of Science ®Google Scholar
• BasaranMKosifRBayarUCivelekBCharacteristics of external genitalia in pre- and postmenopausal womenClimacteric200811541642118781487
   PubMed Web of Science ®Google Scholar
• GoldsteinIRecognizing and treating urogenital atrophy in postmenopausal womenJ Womens Health2010193425432
   Web of Science ®Google Scholar
• BrotmanRMShardellMDGajerPAssociation between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophyMenopause201421545045824080849
   PubMed Web of Science ®Google Scholar
• WinesNWillsteedEMenopause and the skinAustralas J Dermatol200142314916011488706
   PubMedGoogle Scholar
• GandhiJChenADagurGGenitourinary syndrome of menopause: anoverview of clinical manifestations, pathophysiology, etiology, evaluation, andmanagementAm J Obstet Gynecol2016215670471127472999
   PubMed Web of Science ®Google Scholar
• DavilaGWSinghAKarapanagiotouIAre women with urogenital atrophy symptomatic?Am J Obstet Gynecol2003188238238812592244
   PubMed Web of Science ®Google Scholar
• NappiREKokot-KierepaMVaginal Health: Insights, Views & Attitudes (VIVA) – results from an international surveyClimacteric2012151364422168244
   PubMed Web of Science ®Google Scholar
• NappiREPanayNBruyniksNThe clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophyClimacteric201518223324025335119
   PubMed Web of Science ®Google Scholar
• EdwardsDPanayNTreating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?Climacteric201619215116126707589
   PubMed Web of Science ®Google Scholar
• SandhuRSWongTHKlingCAChohanKRIn vitro effects of coital lubricants and synthetic and natural oils on sperm motilityFertil Steril2014101494194424462060
   PubMed Web of Science ®Google Scholar
• VoellerBCoulsonABernsteinGNakamuraRMineral cause of rapid deterioration of latexContraception1989391951022535978
   PubMed Web of Science ®Google Scholar
• BrownJMHessKLBrownSIntravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United StatesObstet Gynecol2013121477378023635677
   PubMed Web of Science ®Google Scholar
• ChenJGengLSongXEvaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trialJ Sex Med20131061575158423574713
   PubMed Web of Science ®Google Scholar
• PickarJHEmerging therapies for postmenopausal vaginal atrophyMaturitas20137513623434231
   PubMed Web of Science ®Google Scholar
• RahnDDCarberryCSansesTVVaginal estrogen for genitourinary syndrome of menopause: a systematic reviewObstet Gynecol201412461147115625415166
   PubMed Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause SocietyMenopause201320988890223985562
   PubMed Web of Science ®Google Scholar
• SucklingJLethabyAKennedyRLocal oestrogen for vaginal atrophy in postmenopausal womenCochrane Database Syst Rev20064CD00150017054136
   PubMed Web of Science ®Google Scholar
• KingsbergSAKrychmanMGrahamSBernickBMirkinSThe Women’s EMPOWER Survey: Identifying Women’s Perceptions on Vulvar and Vaginal Atrophy and Its TreatmentJ Sex Med201714341342428202320
   PubMed Web of Science ®Google Scholar
• ConstantineGDSimonJAPickarJHThe REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyMenopause201724440941627922936
   PubMed Web of Science ®Google Scholar
• SimonJAArcherDFConstantineGDA vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewMaturitas201799515828364869
   PubMed Web of Science ®Google Scholar
• PickarJHAmadioJMBernickBAMirkinSPharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsuleClimacteric201619218118726857443
   PubMed Web of Science ®Google Scholar
• SantenRJVaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levelsClimacteric201518212113425327484
   PubMed Web of Science ®Google Scholar
• NaessenTBerglundLUlmstenUBone loss in elderly women prevented by ultralow doses of parenteral 17beta-estradiolAm J Obstet Gynecol1997177341115119
   Web of Science ®Google Scholar
• NaessenTRodriguez-MaciasKLithellHSerum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly womenJ Clin Endocrinol Metab20018662757276211397883
   PubMed Web of Science ®Google Scholar
• MansonJEChlebowskiRTStefanickMLMenopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trialsJAMA2013310131353136824084921
   PubMed Web of Science ®Google Scholar
• MitchellCMReedSDDiemSEfficacy of vaginal estradiol or vaginal moisturizer vs placebo fot treating postmenopausal vulvo vaginal symptoms: a randomized clinical trialJAMA Intern Med2018178568169029554173
   PubMed Web of Science ®Google Scholar
• PatonDMOspemifene for the treatment of dyspareunia in postmenopausal womenDrugs Today201450535736424918836
   PubMed Web of Science ®Google Scholar
• MirkinSPickarJHSelective estrogen receptor modulators (SERMs): a review of clinical dataMaturitas2015801525725466304
   PubMed Web of Science ®Google Scholar
• ConstantineGDGoldsteinSRArcherDFEndometrial safety of ospemifene: results of the phase 2/3 clinical development programMenopause2015221364324977459
   PubMed Web of Science ®Google Scholar
• PinkertonJVStanczykFZClinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophyMenopause201421330931923777900
   PubMed Web of Science ®Google Scholar
• MoffettAEttingerMBologneseMLasofoxifene, a next generation SERM, is effective in preventing loss of BMD and reducing LDLC in postmenopausal womenJ Bone Miner Res20041996
   Web of Science ®Google Scholar
• McclungMRSirisECummingsSPrevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifeneMenopause200613337738616735934
   PubMed Web of Science ®Google Scholar
• CummingsSEastellREnsrudKThe effects of lasofoxifene on fractures and breast cancer: 3 year results from the PEARL trialJ Bone Miner Res20082381
   Web of Science ®Google Scholar
• GennariLLasofoxifeneGLLasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophyExpert Opin Pharmacother200910132209222019640205
   PubMed Web of Science ®Google Scholar
• KaganRWilliamsRSPanKMirkinSPickarJHA randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenMenopause201017228128919779382
   PubMed Web of Science ®Google Scholar
• LoboRAPinkertonJVGassMLEvaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profileFertil Steril20099231025103819635615
   PubMed Web of Science ®Google Scholar
• KommBSMirkinSEvolution of the tissue selective estrogen complex (TSEC)J Cell Physiol201322871423142723359290
   PubMed Web of Science ®Google Scholar
• PortmanDJLabrieFArcherDFLack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal womenMenopause201522121289129525968836
   PubMed Web of Science ®Google Scholar
• LabrieFArcherDFKoltunWEfficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopauseMenopause201623324325626731686
   PubMed Web of Science ®Google Scholar
• AbrahamseHRegenerative medicine, stem cells, and low-level laser therapy: future directivesPhotomed Laser Surg2012301268168223140266
   PubMed Web of Science ®Google Scholar
• SalvatoreSAthanasiouSCandianiMStefanoSStavrosAMassimoCThe use of pulsed CO2 lasers for the treatment of vulvovaginal atrophyCurr Opin Obstet Gynecol20152761825502427
   PubMed Web of Science ®Google Scholar
• Hutchinson-ColasJSegalSGenitourinary syndrome of menopause therapyMaturitas20158234234526323234
   PubMed Web of Science ®Google Scholar
• SalvatoreSNappiREParmaMSexual function after fractional microablative CO2 laser in women with vulvovaginal atrophyClimacteric201518221922525333211
   PubMed Web of Science ®Google Scholar